Trial Profile
Safety and Efficacy of Intravitreal Conbercept Injection After Vitrectomy for the Treatment of Early Proliferative Diabetic Retinopathy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2020
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 29 Apr 2019 Status changed from active, no longer recruiting to completed.
- 09 Feb 2018 New trial record